ODI Pharma AB (publ) (NGM:ODI)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.080
-0.120 (-5.45%)
At close: May 12, 2025
-72.63%
Market Cap 33.10M
Revenue (ttm) 21.50M
Net Income (ttm) -4.03M
Shares Out 15.92M
EPS (ttm) -0.26
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,808
Average Volume 2,018
Open 2.060
Previous Close 2.200
Day's Range 2.060 - 2.340
52-Week Range 1.500 - 8.050
Beta 0.59
RSI 38.36
Earnings Date May 23, 2025

About ODI Pharma AB

ODI Pharma AB (publ), a pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe. It offers dried flowers; and cosmetics products under the Kandol brand. The company was founded in 2018 and is based in Stockholm, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2018
Employees 1
Stock Exchange Nordic Growth Market
Ticker Symbol ODI
Full Company Profile

Financial Performance

In 2024, ODI Pharma AB's revenue was 22.29 million, an increase of 15880.34% compared to the previous year's 139,457. Losses were -568,059, -91.77% less than in 2023.

Financial Statements

News

There is no news available yet.